Background: Thin-cap fibroatheroma (TCFA) is assumed to cause acute coronary syndromes.

Objective: To compare the accuracy of different models for diagnosing TCFA using parameters derived by CT, validated against optical coherence tomography (OCT).

Methods: One hundred twenty-nine plaques in 106 patients were analyzed using data acquired by 64-row CT with a reconstruction thickness of 0.67 mm and an increment of 0.33 mm. TCFA was defined by OCT as a plaque with lipid content in ≥2 quadrants and the thinnest part of the fibrous cap measuring ≤65 μm. The following parameters were obtained from CT: remodeling index (RI), proportion of low-attenuation (LA) volume (<60 HU), minimum CT number and napkin-ring sign (NRS). We compared three models to predict TCFA: Model 1, RI > 1.1, minimum CT number <30 HU and NRS; Model 2, RI > 1.1, minimum CT number <30 HU or NRS; Model 3, regression model using RI, proportion of LA volume and NRS.

Results: In OCT, 83 plaques fulfilled the criteria of TCFA. The area under the receiver operating characteristics curve significantly (p < 0.01) increased to 0.96 (95% confidence interval (CI), 0.92-1.0) in model 3 as compared to models 1 (0.74, 95% CI, 0.68-0.80) and 2 (0.72, 95% CI, 0.67-0.79). Diagnostic accuracy of model 3 (93%) was significantly higher than that of models 1 (67%, p < 0.001) and 2 (80%, p = 0.001). Sensitivity and specificity of model 3 was 94% and 91%, respectively.

Conclusion: Diagnostic performance to identify TCFA by coronary CTA improves when RI and proportion of LA volume are used as continuous values rather than dichotomizing these parameters.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcct.2017.01.010DOI Listing

Publication Analysis

Top Keywords

thin-cap fibroatheroma
8
optical coherence
8
coherence tomography
8
 11 minimum
8
minimum number
8
accuracy computed
4
computed tomography
4
tomography angiography
4
angiography identify
4
identify thin-cap
4

Similar Publications

Glycemic control and coronary plaque characteristics in patients with acute myocardial infarction.

Int J Cardiol

January 2025

Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin 150086, China; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China, Harbin 150086, China. Electronic address:

Background: The impact of glycemic control on the morphological characteristics of non-culprit lesions (NCLs) in patients with acute myocardial infarction (AMI) remains unclear.

Methods And Results: A total of 800 AMI patients who underwent 3-vessel OCT were divided into three groups based on their serum glycated hemoglobin (HbA1c) levels: poorly controlled diabetes mellitus (DM) (HbA1c ≥8.0 %, n = 79), well controlled DM (6.

View Article and Find Full Text PDF

Non-culprit plaque healing on serial OCT imaging and future outcome in patients with acute coronary syndromes.

Atherosclerosis

January 2025

State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Department of Cardiology of the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China. Electronic address:

Background And Aims: Histologic studies indicated that healed plaque, characterized by a multilayered pattern, is indicative of prior atherothrombosis and subsequent healing. However, longitudinal in vivo data on healed plaque formation in non-culprit plaques are limited. This study aimed to investigate serial changes and clinical significance of new layered pattern formation in non-culprit plaques in patients with acute coronary syndromes (ACS) using serial optical coherence tomography (OCT) imaging.

View Article and Find Full Text PDF

Background: The prevalence of very high-risk atherosclerotic cardiovascular disease (ASCVD) is significant in China, with suboptimal rates of low-density lipoprotein cholesterol (LDL-C) compliance exacerbating plaque instability and causing a higher incidence of major adverse cardiac events (MACEs). Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are effective in reducing LDL-C levels, increase the stability of vulnerable plaque, and influence the progression of atherosclerosis through multiple mechanisms as demonstrated in animal studies. However, there is currently a lack of evidence regarding the efficacy and safety of high-intensity statin therapy combined with PCSK9i in the secondary prevention of ASCVD in the Chinese population.

View Article and Find Full Text PDF

Background: Lipoprotein(a) [Lp(a)] is associated with increased cardiovascular risk, but its influence on plaque characteristics at optical coherence tomography (OCT) evaluation is not fully understood.

Aims: This study seeks to explore the impact of Lp(a) levels on plaque morphology as assessed by OCT in a very high-risk subset of patients.

Methods: Consecutive patients admitted for acute coronary syndrome (ACS) and undergoing OCT-guided percutaneous coronary intervention (PCI) at a large tertiary care center between 2019 and 2022 were deemed eligible for the current analysis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!